Enjoy the long weekend ahead

I'm sure most of you plan to take off for a long weekend soon, and so is the team at Fierce. We'll be back on Tuesday morning to start another week of biotech coverage. Enjoy the time off. -- John Carroll (twitter | email)

Suggested Articles

Creating new, successful central nervous system drugs is tough, and Lundbeck knows this better than most after canning an internal CNS effort.

After seeing later stage trials come through in obesity, Novo Nordisk is canning two projects that were aiming to help reduce patients’ weight.

T-knife has raised €66 million ($78 million) to take four prospects from its TCR-T-cell platform into the clinic in solid tumor indications.